Sunday, July 13, 2014

News: Less Invasive Alternative for Treating Severe Pulmonary Hypertension in Infants

Subcutaneous treprostinil improves outcomes in selected infants with severe pulmonary hypertension and chronic lung disease (CLD) of infancy that have not responded adequately to conservative therapies, researchers say. This is a report of one center’s experience with an extremely small number of carefully selected patients.

One of the co-authors on this paper is Erika Berman-Rosenzweig, MD, a member of PHA's Board of Trustees and Scientific Leadership Council.

Read article

No comments: